Pharmacogenomics Technology Market Product Driving Factors, Capacity and Growth Rate Analysis to 2025

The scope of the global Pharmacogenomics Technology Market was appreciated by US$ 5.62 billion in 2016 and it is likely to reach US$ 18.3 billion during the forecast period. This could be attributed to growth in geriatric population, prevalence of chronic diseases like HIV, tuberculosis, and cancer, increase in awareness amongst the patients regarding personalized therapy, and adoption of pharmacogenomics by loads of healthcare professionals.

The pharmacogenomics technology market is also likely to get bolstered technological advancements related to molecular diagnostics. At the same time, there is a dearth on the part of highly skilled and trained healthcare professionals in conducting pharmacogenomics diagnostics tests. Besides, emerging economies need to think twice before affirming pharmacogenomics tests as initial as well as operating costs are high. Governments herein do struggle with funding on this count.

Request a Sample Copy of Pharmacogenomics Technology Market Report @ https://www.millioninsights.com/industry-reports/pharmacogenomics-technology-market/request-sample

Therapeutic Area Outlook (Revenue, USD Million; 2014 - 2025)

    • Oncology

        • Lung Cancer

        • Breast Cancer

        • Colorectal Cancer

        • Cervical Cancer

        • Others

    • Neurological Disorders

    • Cardiovascular Disease

    • Immunological Disorders

    • Others

Technology Outlook (Revenue, USD Million; 2014 - 2025)

    • PCR

    • In-situ Hybridization

    • Immunohistochemistry

    • Sequencing

    • Others

The players contributing to the pharmacogenomics technology market include OPKO Health, Inc., Thermo Fisher Scientific, Inc., Teva Pharmaceutical Industries Ltd., Dynamic DNA Laboratories, Abbott Laboratories, F. Hoffmann-La Roche Ltd., One Ome LLC, Empire Genomics, LLC, and Illumina, Inc.

Access Pharmacogenomics Technology Market Report with TOC @ https://www.millioninsights.com/industry-reports/pharmacogenomics-technology-market

North America rules the roost; thanks to extensive investment in healthcare by the U.S. Europe comes in second due to Belgium and Denmark being on the top pedestal with respect to healthcare. Asia Pacific is expected to grow at the fastest pace owing to increase in awareness among the economies like India and China regarding healthcare. LATAM will also catch up due to presence of Brazil; followed by MEA. In fact, MEA would be more vigilant on this count; due to the figures released by WHO. It says that over 50% of the diseases mentioned above occur in sub-Saharan Africa.

Comments

Post a Comment

Popular posts from this blog

Spinal Implants & Devices Market Forecast Analysis by Manufacturer, Types, Applications and Regions 2023 – 2030

  Spinal Implants & Devices Industry Overview The global  Spinal Implants & Devices Market  size is expected to reach USD 19.0 billion by 2030 and is expected to expand at a CAGR of 5.2% in the forecast period, from 2023 to 2030, according to a new report by Grand View Research, Inc. The growing number of vehicular accidents is leading to increasing new cases of spinal cord injuries (SCIs). Other causes of SCIs include falls, violence, acts of violence, sports and recreation injuries, and diseases. Vehicular or road accidents and falls account for the majority of SCI cases. Fall-induced SCI is common among people aged 65 years and above. Acts of violence such as gunshot wounds or knife wounds account for around 12% of SCI cases. Sports activities such as diving in shallow water and impact sports lead to nearly 10% of SCIs. Cancer, osteoporosis, arthritis, and inflammation of the spinal cord also cause SCI. Based on National Spinal Cord Injury Statistical Center data, around 296
Read more

Latin America Pharmaceutical Contract Manufacturing & Research Services Market Overview, Cost Structure Analysis and Forecast to 2030

  Latin America Pharmaceutical Contract Manufacturing & Research Services Industry Overview The  Latin America Pharmaceutical Contract Manufacturing & Research Services Market  size is expected to reach USD 40.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 7.5% from 2022 to 2030. The low cost of drug registration in Latin American countries and the economic growth are the key factors contributing to progress in this region. Moreover, factors such as the growing demand for generics, rising investments in R&D, the growing geriatric population, and the increasing burden of chronic diseases are responsible for market growth. The outbreak of COVID-19 has boosted the market growth as companies have increased investments in R&D and manufacturing to develop vaccines and drugs against the COVID-19. During the coronavirus outburst, the supply chains of biopharmaceutical companies remained robust and were larg
Read more

Coffee Roasters Market Insights, Growth Factors and Forecast Analysis till 2025

Image
01 st November 2018 - Global Coffee Roasters Market is segmented on the basis of energy source, flavor, product type, mode of operation, application and region. Coffee is one of the world’s most popular beverages. Coffee roaster is a machine for coffee roasting. Roasting coffee does transform the physical and chemical properties of green coffee beans into various roasted coffee products. The process of roasting gives typical flavor of coffee by causing green coffee beans to expand and change in taste, color, density, and smell. Raw beans do contain similar protein, acids, and caffeine as those that have been roasted, but lag behind as far as taste is concerned. Request a Sample Copy of Coffee Roasters Market Report @ https://www.millioninsights.com/industry-reports/coffee-roasters-market/request-sample Majority of coffee is roasted commercially on a large scale, but some coffee drinkers roast coffee at home for exercising more control over the flavor and freshness profil
Read more